2 hours ago, Penny Mordaunt stated that the government will not modify Commons procedure to allow all MPs to interrogate Lord Cameron on foreign affairs. An hour ago, Labour criticized the Tory response to Mark Menzies allegations as inadequate and suggested involving the police. Recent polls indicate that Rishi Sunak’s approval rating as Prime Minister has hit a record low. Additionally, Grant Shapps criticized Labour over the Rwanda bill and proposed the use of RAF planes for deportation. The Ipsos polling company has released charts showing Sunak’s approval rating compared to other prime ministers, as well as Keir Starmer’s ratings compared to other opposition leaders. Starmer’s leadership has significantly boosted his party’s popularity, making him more successful than any opposition leader since Tony Blair. In another development, Neil Gray, the Scottish government’s health secretary, praised two health boards for pausing the prescription of puberty blockers to new patients, a decision supported by Scotland’s chief medical officer. The Scottish government and boards are reviewing the recommendations of the Cass Review. During business questions, Lucy Powell questioned why the government is unwilling to amend parliamentary rules to allow all MPs to question Lord Cameron on foreign affairs.
Poll Shows Rishi Sunak’s Approval Rating Plummeting to Historic Lows as UK Politics Unfold Live
-
By ad-astra
- Categories: World
Related Content
Nigel Railton, Former Camelot CEO, Takes the Helm as Post Office Chairman
By
ad-astra
May 1, 2024
Captivating Images: Southeast Asia Sizzles in Unprecedented Heatwave
By
ad-astra
May 1, 2024
Dushanbe Raises Concerns with Russia Regarding Tajik Citizens' Rights Abuses
By
ad-astra
May 1, 2024
Queensland Labor's Youth Detention Reforms Spark Outrage Among Justice Advocates
By
ad-astra
May 1, 2024
The Rise and Fall of Myanmar's Myawaddy: The Story of a Sanctioned Strongman
By
ad-astra
May 1, 2024
Russian Airstrikes Decimate Odesa: Innocent Civilians Targeted in Brutal Attacks
By
ad-astra
April 30, 2024
Can Biotech Innovators Outshine Industry Giants Eli Lilly and Novo Nordisk?
By
ad-astra
April 30, 2024